16:01 Dec 05

Everest Organics Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
437.90
+26.20 (+6.36%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Everest Organics Ltd. Financials

Everest Organics Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
437.90
+26.20 (+6.36%)
16:01 Dec 05
Quality
image/svg+xml

41/100
Medium Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

61/100
Technically Moderately Bullish

Strength

5

Weakness

5

Opportunity

0

Threats

0

-1.84 %

ROE %

-0.57 %

ROA %

0.00

EPS

72.03

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
200.05 183.05 197.24 159.48 180.84
Operating Expenses +
193.62 182.12 186.25 152.26 165.54
Raw Material
140.36 124.9 123.41 97.5 109.31
Increase Decrease in Cost
-4.51 -3.23 0.56 1.04 4.05
Other Manufacturing Expense
30.38 32.44 30.66 0 0
Employee Cost
16.33 16.3 18.8 16.35 15.91
Miscellaneous Expenses
11.06 11.71 12.82 37.37 36.27
Operating Profit
6.43 0.93 10.99 7.22 15.3
Other Income
2.21 6.94 0.89 0.69 0.91
Depreciation
3.8 4.47 5.8 5.96 6.02
Interest
3.1 3.31 5.47 5.19 5.21
Profit before tax and exceptio..
1.74 0.09 0.61 -3.24 4.98
Exceptional Items
0 0 0 0 0
PBT
1.74 0.09 0.61 -3.24 4.98
Provision for Taxation
0.6 0.27 0.47 -1.95 -1.18
Net Profit
1.14 -0.18 0.14 -1.29 6.2
NET Profit after MI
0 0 0 0 0
EPS
1.43 -0.23 0.17 -2.97 5.15
Operating Profit Margin (%)
3.21 0.51 5.57 4.53 8.46
Net Profit Margin (%)
0.57 -0.1 0.07 -0.81 3.43

Everest Organics Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 59.60 61.00 61.10 74.20 74.20 74.20
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.10
Others 40.40 39.00 38.90 25.80 25.80 25.70
Shareholder Shares Holding %
Download Our App On: